Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens

Human Molecular Genetics

Volumn 6, Issue 12, 1997, Pages 2099-2107

  Mak, Victor ^a,b,c   Jarvi, Keith A ^a,c   Zielenski, Julian ^b   Durie, Peter ^b,c,d   Tsui, Lap Chee ^b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EXON; GENE DELETION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; INTRON; MALE; MALE GENITAL TRACT MALFORMATION; MALE INFERTILITY; NOSE MUCOSA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM; VAS DEFERENS; VASECTOMY;

ALLELES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIUM; EXONS; GENOTYPE; HUMANS; INTRONS; MALE; NASAL MUCOSA; POLY T; POLYMERASE CHAIN REACTION; RNA, MESSENGER; VAS DEFERENS;

EID: 0030687683     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.12.2099     Document Type: Article

References (47)

1. Welsh, M.J., Tsui, L.-C., Boat, T.F. and Beaudet, A.L. (1995) In Seriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, Vol 3, pp.3799-3876.
2. Kaplan, E., Shwachman, H., Perlmutter, A.D., Rule, A., Khaw, K.T. and Holsclaw, D.S. (1968) Reproductive failure in males with cystic fibrosis. N. Engl. J. Med., 279, 65-69.
3. Valman, H.B. and France, N.E. (1969) The vas deferens in cystic fibrosis. Lancet, ii, 566-567.
4. Landing, B.H., Wells, T.R. and Wang, C.-I. (1969) Abnormality of the epididymis and vas deferens in cystic fibrosis. Arch. Path., 88, 569-580.
5. Taussig, L.M., Lobeck, C.C., di Sant' Agnese, P.A., Ackerman, D.R. and Kattwinkel, J. (1972) Fertility in males with cystic fibrosis. N. Engl. J. Med., 287, 586-589.
6. Anguiano, A., Oates, R.D., Amos, J.A., Dean, M., Gerrard, B., Stewart, C., Maher, T.A., White, M.B. and Milunsky, A. (1992) Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA. 267, 1794-1797.
7. Patrizio, P., Asch, R.H., Handelin, B. and Silber, SJ. (1993) Aetiology of congenital absence of vas deferens: genetic study of three generations. Hum. Reprod., 8, 215-220.
8. Osbome, L.R., Lynch, M., Middleton, P.G., Alton, E.W.F.W., Geddes, D.M., Pryor, J.P., Hodson, M.E. and Santis, G.K. (1993) Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum. Mol. Genet., 2, 1605-1609.
9. Culard, J.-F., Desgeorges, M., Costa, P., Laussel, M., Razakatzara, G., Navratil, H., Demaille, J. and Claustres, M. (1994) Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral aplasia of epididymis or vas deferens. Hum. Genet., 93, 467-470.
10. Oates, R.D. and Amos, J. A. (1994) The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J. Androl., 15, 1-8.
11. Mercier, B., Verlingue, C., Lissens, W., Silber, S.J., Novelli, G., Bonduelle, M., Audrezet, M.P. and Ferec, C. (1995) Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am. J. Hum. Genet., 56, 272-277.
12. Chillon, M., Casals, T., Mercier, B., Bassas, L., Lissens, W., Silber, S., Romey, M.-C., Ruiz-Romero, J., Verlingue, C., Claustres, M., Nunes, V., Ferec, C. and Estivill, X. (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med., 332, 1475-1480.
13. Zielenski, J., Patrizio, P., Corey, M., Handelin, B., Markiewicz, D., Asch, R. and Tsui, L.-C. (1995) CFTR gene variant for patients with congenital absence of vas deferens. Am. J. Hum. Genet., 57, 958-960.
14. Costes, B., Girodon, E., Ghanem, N., Flori, E., Jardin, A., Soufir, J.C. and Goossens, M. (1995) Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens. Eur. J. Hum. Genet., 3, 285-93.
15. Schlegel, P.N., Shin, D. and Goldstein, M. (1996) Urogenital anomalies in men with congenital absence of the vas deferens. J. Urol., 155, 1644-1648.
16. Donat, R., McNeill, A.S., Fitzpatrick, D.R. and Hargreave, T.B. (1997) The incidence of cystic fibrosis gene mutations in patients with congenital bilateral absence of the vas deferens in Scotland. Br. J. Urol., 79, 74-77.
17. Jarvi, K., Zielenski, J., Wilschanski, M., Durie, P., Buckspan, M., Tullis, E., Markiewicz, D. and Tsui, L.-C. (1995) Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet, 345, 1578.
18. Chu, C.-S., Trapnell, B.C., Murtagh, J.J., Moss, J., Dalemans, W., Jallat, S., Mercenier, A., Pavirani, A., Lecocq, J.-P., Cutting, G.R., Guggino, W.B. and Crystal, R.G. (1991) Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J., 10, 1355-1363.
19. Chu, C.-S., Trapnell, B.C., Curristin, S.M., Cutting, G.R. and Crystal, R.G. (1992) Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J. Clin. Invest. 90, 785-790.
20. Chu, C.-S., Trapnell, B.C., Curristin, S.M., Cutting, G.R. and Crystal, R.G. (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet., 3, 151-156.
21. Strong, T.V., Wilkinson, d.J., Mansoura, M.K., Devor, D.C., Genze, K., Yang, Y., Wilson, J.M., Cohn, J.A., Dawaon, D.C., Frizzell, R.A. and Collins, F.S. (1993) Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum. Mol. Genet., 2, 225-230.
22. Delaney, S.J., Rich, D.P., Thomson, S.A., Hargrave, M.R., Lovelock, P.K., Welsh, M.J. and Wainwright, B.J. (1993) Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nature Genet., 4, 426-431.
23. Kiesewetter, S., Macek, M Jr., Davis, C., Curristin, S. M., Chu, C.S., Graham, C., Shrimpton, A.E., Cashman, S.M., Tsui L.-C., Mickle, J., Amos, J., Highsmith, W.E., Shuber, A., Witt, D.R., Crystal, R.G. and Cutting, G.R. (1993) A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet., 5, 274-278.
24. Cuppens, H., Teng, H., Raeymaekers, P., De Boeck, C. and Cassiman, J.J. (1994) CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum. Mol. Genet., 3, 607-614.
25. Dork, T., Fislage, R., Neumann, T., Wulf, B. and Tummler, B. (1994) Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations. Hum. Genet., 93, 67-73.
26. Teng, H., Jorissen, M., Van Poppel, H., Legius, E., Cassiman, J.-J. and Cuppens, H. (1997) Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum. Mol. Genet., 6, 85-90.
27. Rave-Harel, N., Kerem, E., Nissim-Rafinia, M., Madjar, I., Goshen, R., Augarten, A., Rahat, A., Hurwitz, A., Darvasi, A. and Kerem, B. (1997) The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am. J. Hum. Genet., 60, 87-94.
28. Kristidis, P., Bozon, D., Corey, M., Markiewicz, D., Rommens, J., Tsui, L.-C. and Durie, P. (1992) Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet., 50, 1178-1184.
29. Hamosh, A., Corey, M. and the Cystic fibrosis genotype/phenotype consortium. (1994) Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med., 329, 1308-1313.
30. - channels with altered pore properties. Nature, 362, 160-164.
31. Walsh, P.S., Erlich, H.A. and Higuchi, R. (1992) Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appl., 1, 241-242.
32. Lodish, H., Baltimore, D., Berk, A., Zipursky, S.L., Matsudaira, P. and Darnell, J. (1995) Transcription termination, RNA processing, and posttranscriptional control. In: Molecular Cell Biology. Edited by H. Lodish, D.Baltimore, A. Berk, Zipursky, S.L., P. Matsudaira and J. Darnell. New York: W.H. Freeman and Company, pp. 485-542.
33. Krainer, A.R. and Maniatis, T. (1988) RNA splicing. In: Transcription and Splicing. Edited by B.D. Hames and D.M. Glover. Oxford: IRL Press, pp. 131-206.
34. Helfman, D.M. and Ricci, W.M. (1989) Branch point selection in alternative splicing of tropomyosin pre-mRNAs. Nucleic Acids Res., 17, 5633.
35. Smith, C.W.J. and Nadal-Ginard, B. (1989) Mutually exclusive splicing of alpha-tropomyosin exons enforced by an unusual lariat branch point location: implications for constitutive splicing. Cell, 56, 749.
36. Frendeway, D. and Keller, W. (1985) The stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences. Cell, 42, 355.
37. Reed, R. and Maniatis, T. (1986) A role for exon sequences and splice-site proximity in splice-site selection. Cell, 46, 681.
38. Ruskin, B. and Green, M.R. (1985) Role of the 3′ splice site consensus sequence in mammalian pre-mRNA splicing. Nature, 317, 732.
39. Ruskin, B., Zamore, P.D. and Green, M.R. (1988) A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell, 52, 207.
40. Breibart, R.E. and Nadal-Ginard, B. (1987) Developmentally induced, muscle specific trans factors control the differential splicing of alternative and constitutive troponin-T exons. Cell, 49, 793.
41. Wieczorek, D., Smith, C.W.J. and Nadal-Ginard, B. (1988) The rat α-tropomyosin gene generates a minimum of six different mRN As coding for striated, smooth and non-muscle isoforms by alternative splicing. Mol. Cell Biol., 8, 679.
42. Mak, V. and Jarvi, K.A. (1996) The genetics of male infertility. J. Urol., 156, 1245-1257.
43. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
44. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. and Erlich, H. (1986) Specific enzymatic amplication of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol., 51, 263-273.
45. Zielenski, J., Rozmahel, R., Bozon, D., Kerem, B., Grzelczak, Z., Riordan, J.R., Rommens, J. and Tsui, L.-C. (1991) Genomic DNA sequence of the cystic fibrosis transmembrane regulator (CFTR) gene. Genomics, 10, 214-228.
46. Rommens, J.M., Dho, S., Bear, C.E., Kartner, N., Kennedy, D., Riordin, J.R., Tsui, L.-C. and Foskett. J.K. (1991) cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA, 88, 7500-7504.
47. Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503-517.